Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX) N Kunøe, A Opheim, KK Solli, Z Gaulen, K Sharma-Haase, ZH Latif, ... BMC Pharmacology and Toxicology 17, 1-10, 2016 | 37 | 2016 |
Health and social issues among older patients in opioid maintenance treatment in Norway Z Gaulen, SE Alpers, SEL Carlsen, S Nesvåg Nordic Studies on Alcohol and Drugs 34 (1), 80-90, 2017 | 15 | 2017 |
Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: extension of a randomized clinical trial KK Solli, N Kunoe, ZEH Latif, K Sharma-Haase, A Opheim, P Krajci, ... European addiction research 25 (6), 303-309, 2019 | 13 | 2019 |
Beyond medication: life situation of older patients in opioid maintenance treatment SEL Carlsen, Z Gaulen, SE Alpers, M Fjaereide Addiction Research & Theory 27 (4), 305-313, 2019 | 8 | 2019 |
Interest in extended release naltrexone among opioid users K Sharma Haase, N Kunøe, A Opheim, Z Gaulen, ALM Njå, ZE Latif, ... European addiction research 22 (6), 301-305, 2016 | 8 | 2016 |
The predictive value of degree of preference for extended-release naltrexone for treatment adherence, opioid use, and relapse Z Gaulen, IH Brenna, LT Fadnes, J Šaltytė Benth, KK Solli, N Kunoe, ... European Addiction Research 28 (1), 56-67, 2022 | 5 | 2022 |
Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial A Opheim, Z Gaulen, KK Solli, ZH Latif, LT Fadnes, JŠ Benth, N Kunøe, ... The American Journal on Addictions 30 (5), 453-460, 2021 | 4 | 2021 |
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up Z Gaulen, JŠ Benth, LT Fadnes, IH Brenna, L Tanum Journal of Substance Abuse Treatment 135, 108656, 2022 | 2 | 2022 |
Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial A Opheim, JŠ Benth, KK Solli, PS Kloster, LT Fadnes, N Kunøe, Z Gaulen, ... Contemporary Clinical Trials 135, 107360, 2023 | 1 | 2023 |
An Overview of Youth Substance Abuse Recovery Strategies in Norway Z Gaulen, SEL Carlsen Journal of Groups in Addiction & Recovery 11 (4), 228-239, 2016 | 1 | 2016 |
Pre-treatment preference, opioid use, and life satisfaction among heroin dependent users receiving treatment with buprenorphine-naloxone or extended-release naltrexone: A 12 … Z Gaulen The University of Bergen, 2023 | | 2023 |
Front & Back Matter M Bleckwenn, L Heister, M Weckbecker, K Weckbecker, M Mücke, ... European Addiction Research 22 (6), 2016 | | 2016 |